Drug intelligence / Profile preview

Saccharomyces boulardii + zinc

Development stage: Unknown
Lead developer: Biocodex
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Saccharomyces boulardii + zinc is a combination therapy investigated for the treatment of acute watery diarrhea in pediatric patients. Saccharomyces boulardii is a non-pathogenic, transient yeast probiotic that helps restore the intestinal microflora, inhibits the growth of enteric pathogens, and neutralizes bacterial toxins. Zinc is an essential trace element that reduces the duration and severity of diarrhea by supporting intestinal mucosal repair, improving water and electrolyte absorption, and enhancing the local immune response. The combination is specifically used to improve clinical outcomes, such as reducing the time to resolution of diarrhea and vomiting, in children under five years of age.

Other names: S. boulardii + zinczinc + Saccharomyces boulardii

Beyond the preview

Go deeper on Saccharomyces boulardii + zinc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Saccharomyces boulardii + zinc.

Explore the full profile